» Articles » PMID: 30181289

Cancer-driving H3G34V/R/D Mutations Block H3K36 Methylation and H3K36me3-MutSα Interaction

Overview
Specialty Science
Date 2018 Sep 6
PMID 30181289
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Somatic mutations on glycine 34 of histone H3 (H3G34) cause pediatric cancers, but the underlying oncogenic mechanism remains unknown. We demonstrate that substituting H3G34 with arginine, valine, or aspartate (H3G34R/V/D), which converts the non-side chain glycine to a large side chain-containing residue, blocks H3 lysine 36 (H3K36) dimethylation and trimethylation by histone methyltransferases, including SETD2, an H3K36-specific trimethyltransferase. Our structural analysis reveals that the H3 "G33-G34" motif is recognized by a narrow substrate channel, and that H3G34/R/V/D mutations impair the catalytic activity of SETD2 due to steric clashes that impede optimal SETD2-H3K36 interaction. H3G34R/V/D mutations also block H3K36me3 from interacting with mismatch repair (MMR) protein MutSα, preventing the recruitment of the MMR machinery to chromatin. Cells harboring H3G34R/V/D mutations display a mutator phenotype similar to that observed in MMR-defective cells. Therefore, H3G34R/V/D mutations promote genome instability and tumorigenesis by inhibiting MMR activity.

Citing Articles

Emerging roles of cancer-associated histone mutations in genomic instabilities.

Yadav P, Jain R, Yadav R Front Cell Dev Biol. 2024; 12:1455572.

PMID: 39439908 PMC: 11494296. DOI: 10.3389/fcell.2024.1455572.


Histone H3 mutations and their impact on genome stability maintenance.

Caeiro L, Verdun R, Morey L Biochem Soc Trans. 2024; 52(5):2179-2191.

PMID: 39248209 PMC: 11580799. DOI: 10.1042/BST20240177.


Molecular and Pathological Features of Paediatric High-Grade Gliomas.

Blasco-Santana L, Colmenero I Int J Mol Sci. 2024; 25(15).

PMID: 39126064 PMC: 11312892. DOI: 10.3390/ijms25158498.


Beyond the Usual Suspects: Examining the Role of Understudied Histone Variants in Breast Cancer.

Dhahri H, Saintilnord W, Chandler D, Fondufe-Mittendorf Y Int J Mol Sci. 2024; 25(12).

PMID: 38928493 PMC: 11203562. DOI: 10.3390/ijms25126788.


Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.

Nacev B, Dabas Y, Paul M, Pacheco C, Mitchener M, Perez Y Nat Commun. 2024; 15(1):5155.

PMID: 38886411 PMC: 11183192. DOI: 10.1038/s41467-024-49486-5.


References
1.
Haber J . DNA Repair: The Search for Homology. Bioessays. 2018; 40(5):e1700229. PMC: 6238635. DOI: 10.1002/bies.201700229. View

2.
Petermann E, Orta M, Issaeva N, Schultz N, Helleday T . Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell. 2010; 37(4):492-502. PMC: 2958316. DOI: 10.1016/j.molcel.2010.01.021. View

3.
Li R, Yu C, Li Y, Lam T, Yiu S, Kristiansen K . SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics. 2009; 25(15):1966-7. DOI: 10.1093/bioinformatics/btp336. View

4.
Behjati S, Tarpey P, Presneau N, Scheipl S, Pillay N, Van Loo P . Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013; 45(12):1479-82. PMC: 3839851. DOI: 10.1038/ng.2814. View

5.
Sturm D, Witt H, Hovestadt V, Khuong-Quang D, Jones D, Konermann C . Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012; 22(4):425-37. DOI: 10.1016/j.ccr.2012.08.024. View